Duolink – Discover More About Protein-Protein Interactions
The Duolink® reagent kit enables you to visualise, localise and quantify proteins, their interactions and modifications in unmodified cells and tissues.
The Duolink® reagent kit enables you to visualise, localise and quantify proteins, their interactions and modifications in unmodified cells and tissues.
Pfizer globally licenses ChemAxon’s platform for Markush structure searching and enumeration.
In response to steady increase in business and a broader service offering, ChemAxon has expanded office space, approximately doubling the available facilities at the Budapest head office.
Compound registration, structure search and computed properties rolled out.
The Chemicalize website from ChemAxon is gaining interest and, likely, LOTS of users! Chemicalize is both a website for recognising chemical names and converting to chemical structures as well as an integration path to their property prediction algorithms.
Yokohama, Japan and Budapest, Hungary, RIKEN and ChemAxon, a leading provider of cheminformatics software for the life sciences industry, announced the licensing of ChemAxon’s Instant JChem for the Drug Discovery Computational Chemistry Platform Unit (SSBC) at RIKEN. The software is to be used to support registration processes and for data distribution and analysis.
Eurand, a global specialty pharmaceutical company, has recently partnered with Prestige Brands Holdings, Inc. on a new orally disintegrating tablet (ODT) formulation of its over-thecounter (OTC) sleep-aid, Sleep-eze®.
A newly published article by Malvern Instruments diffraction specialist Dr Anne Virden provides detailed guidance on how to develop a robust method for laser diffraction particle size analysis.
On 2 Nov 2010 Patcore Inc. and ChemAxon, a leading provider of cheminformatics software for the life sciences industry, announced the licensing of ChemAxon’s JChem for the Japanese Consortium for Glycobiology and Glycotechnology Database (JCGGDB).
Lonza and California Peptide Research, Inc. (CPRI) have entered into a strategic collaboration to more effectively serve customers requesting peptide manufacturing and development services.